Blood biomarker levels of methylation capacity in autism spectrum disorder: a systematic review and meta‐analysis
Authors:
- 16 March 2020
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 141 (6) , 492-509
Abstract
Objective: To compare the peripheral blood levels of methionine (Met), S‐adenosylmethionine (SAM), S‐adenosylhomocysteine (SAH), and the SAM/SAH ratio (the most core and predictive indices of cellular methylation ability) between patients with autism spectrum disorder (ASD) and control subjects.Methods: PubMed, Embase, PsycINFO, Web of Science, and Cochrane Library were searched from inception to August 2, 2019, without language restriction. The random‐effects model was used to summarize effect sizes.Results: We retrieved 1,493 records, of which 22 studies met inclusion criteria. Our overall analyses revealed that individuals with ASD had significantly decreased levels of Met (22 studies; Hedges’ g = −0.62; 95% confidence interval [CI]: −0.89, −0.35), SAM (8 studies; Hedges’ g = −0.60; 95% CI: −0.86, −0.34), and the SAM/SAH ratio (8 studies; Hedges’ g = −0.98; 95% CI: −1.30, −0.66) and significantly increased levels of SAH (8 studies; Hedges’ g = 0.69; 95% CI: 0.43, 0.94). The findings of the overall analyses were quite stable after being verified by sensitivity analyses and in agreement with the corresponding outcomes of subgroup analyses. Additionally, our results from meta‐analytic techniques confirmed that the effect estimates of this meta‐analysis did not originate from publication bias.Conclusion: Individuals with ASD have substantially aberrant peripheral blood levels of Met, SAM, SAH, and the SAM/SAH ratio, which supports the association between impaired methylation capacity and ASD. Therefore, further investigations into these indices as potential biomarkers for diagnosis and therapeutic targets of ASD are warranted.Keywords
This publication has 61 references indexed in Scilit:
- Effect of a vitamin/mineral supplement on children and adults with autismBMC Pediatrics, 2011
- Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning AutismPLOS ONE, 2011
- Metabolic Imbalance Associated with Methylation Dysregulation and Oxidative Damage in Children with AutismJournal of Autism and Developmental Disorders, 2011
- Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severityNutrition & Metabolism, 2011
- Hypothesis: a Unifying Mechanism for Nutrition and Chemicals as Lifelong Modulators of DNA HypomethylationEnvironmental Health Perspectives, 2009
- Novel plasma phospholipid biomarkers of autism: Mitochondrial dysfunction as a putative causative mechanismProstaglandins, Leukotrienes and Essential Fatty Acids, 2009
- One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disordersJournal of Cellular and Molecular Medicine, 2009
- Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autismThe American Journal of Clinical Nutrition, 2009
- Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autismAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002